Yes. An overdose can cause cardiac arrest, and it usually does so through one of four final pathways: the heart stops receiving oxygen, the heart's electrical system destabilizes, the pump muscle is directly poisoned, or blood pressure collapses so far that coronary perfusion fails. Which pathway dominates depends on the substance, the dose, the speed of exposure, and the person's baseline health. The gap between a survivable overdose and a fatal one is often minutes, not hours.
This explainer goes deeper than the standard "drugs are bad for your heart" summary. It walks through the actual electrophysiology, the published dose ranges where cardiac arrest becomes plausible, the counterintuitive cases that trip up clinicians, and the practical thresholds that change outcomes. It is educational only and is not a substitute for emergency care. If someone may be overdosing, call 911 immediately.
The final common pathway is oxygen, not toxicity
Cardiac arrest means the heart stops pumping effectively. In overdose, that can happen because the heart itself fails, or because the brain and lungs fail first and the heart follows. The second route is more common than most people assume. Opioids, sedatives, and alcohol kill primarily by suppressing the brainstem's drive to breathe. When breathing slows enough, blood oxygen falls, the heart muscle becomes hypoxic, and a hypoxic heart eventually stops. This is why naloxone, which reverses opioid breathing suppression, can prevent cardiac arrest without ever touching the heart directly.
The distinction matters clinically. A person who stops breathing from an opioid overdose has a reversible cause if reversed early. A person whose heart has already entered ventricular fibrillation from a stimulant overdose has a much narrower window. The same word, overdose, describes two very different emergencies.
How specific substances stop the heart
Different drug classes reach cardiac arrest through distinct mechanisms, and understanding them explains why treatments differ.
Opioids and other respiratory depressants cause arrest through profound hypoventilation. The medulla's CO2 sensors lose sensitivity, respiratory rate drops below the level needed to clear carbon dioxide, and progressive hypoxia and hypercapnia follow. The heart is initially healthy. It arrests because it is starved of oxygen and acidotic. This is the most reversible overdose cardiac arrest when bystanders act fast.
Sodium-channel-blocking drugs, including tricyclic antidepressants and certain local anesthetics, poison the heart's electrical conduction. These drugs bind sodium channels in the ventricular muscle and slow the upstroke of the cardiac action potential. The result is a widened QRS complex on the ECG, then ventricular tachycardia, then ventricular fibrillation. This is a direct electrical poisoning, not an oxygen problem.
Stimulants such as cocaine and methamphetamine drive massive catecholamine release. Heart rate and blood pressure spike, coronary arteries can spasm, and the myocardium's oxygen demand outstrips supply. The result is often ischemia, arrhythmia, or frank myocardial infarction, which can degenerate into arrest. Cocaine also blocks sodium channels, so it combines two mechanisms at once.
Potassium disturbances are the quiet killer. Digoxin overdose and massive cell breakdown from other toxins raise or lower serum potassium in ways that destabilize cardiac membranes. A potassium shift alone can trigger ventricular fibrillation even when oxygen and blood pressure look acceptable.
Calcium-channel blockers and beta-blockers remove the heart's normal pacing and contractile drive. The heart rate slows, contractility falls, and blood pressure drops until coronary perfusion is inadequate. This is a pump-and-pressure failure rather than an electrical one, though bradyasystolic arrest is the usual endpoint.
Quantified context: where the risk curve steepens
Precise lethal doses are drug-specific and highly individual, so no universal threshold exists. But published ranges show where cardiac arrest becomes a realistic concern.
For opioids in opioid-naive adults, respiratory depression typically begins at doses well above analgesic thresholds, and the risk rises steeply with dose, speed of administration, and co-use of sedatives or alcohol. Combining an opioid with a benzodiazepine or alcohol multiplies respiratory risk because each drug suppresses breathing through a different receptor system. This is why polysubstance overdose is so much more lethal than any single drug.
For tricyclic antidepressants, QRS widening beyond roughly 100 to 120 milliseconds signals sodium-channel toxicity and predicts arrhythmia risk. Clinicians use this ECG threshold, not a blood level, to decide on sodium bicarbonate therapy. The drug level matters less than the electrical footprint.
For cocaine, chest pain and arrhythmia can occur at doses far below what users consider typical, especially with underlying coronary disease. Cocaine-related cardiac events are not confined to heavy users.
For calcium-channel blockers, sustained-release formulations are more dangerous than immediate-release ones because toxicity can be delayed and prolonged. A patient who looks stable at four hours may deteriorate at twelve.
The honest limitation: these are ranges from toxicology literature, not guarantees. Individual tolerance, genetics, kidney and liver function, and co-ingestants shift every threshold. No number substitutes for clinical assessment.
Timeline: how fast an overdose arrests the heart
| Time from exposure | What is happening | Arrest risk |
|---|---|---|
| 0–5 minutes | Absorption; stimulant surge or rapid sedative effect | High for injected stimulants and fast-acting depressants |
| 5–30 minutes | Respiratory rate falls (depressants) or arrhythmia begins (stimulants) | Rising; bystander action is decisive |
| 30–60 minutes | Hypoxia, acidosis, or ECG changes develop | High without intervention |
| 1–4 hours | Peak toxicity for many immediate-release drugs | Peak arrest window for many agents |
| 4–12 hours | Delayed toxicity from sustained-release drugs | Persistent risk; do not discharge early |
| 12–24 hours | Most immediate-release crises resolved if treated | Lower but not zero with long-acting agents |
| 24–72 hours | Complications: aspiration, organ injury, delayed arrhythmia | Falling; monitoring still matters |
This table is a general pattern. Specific drugs deviate, and the professional caveat is that a stable patient at hour four is not necessarily safe.
Edge cases that break the simple rule
The counterintuitive detail worth internalizing: a person can have a fatal cardiac arrest from an overdose while their blood drug level looks modest. Tolerance is the reason. An opioid-tolerant patient may survive a dose that kills an opioid-naive person, and a patient who has lost tolerance after a period of abstinence may die from a dose they previously used routinely. Toxicology results can mislead investigators because the same blood concentration means different things in different people.
Another edge case is the "walking wounded" stimulant user. Cocaine and methamphetamine can cause coronary vasospasm and arrhythmia in a person who feels fine and has normal vital signs at triage. The arrest can occur after discharge. Clinicians are taught to observe longer than vital signs alone suggest.
Common misconceptions, corrected
A persistent belief is that cardiac arrest from overdose is always the heart's fault. In fact, respiratory arrest precedes cardiac arrest in most depressant overdoses, which is why rescue breathing and naloxone save lives. Another misconception is that a dose "too small" to matter is safe. For stimulants in people with coronary disease, and for sodium-channel blockers in children, small doses have caused arrests. A third is that reversal agents fix everything. Naloxone reverses opioids but not the hypoxia already suffered, and it does nothing for stimulant, sodium-channel, or calcium-channel toxicity.
Practical actions and warning signs
The actionable threshold is simple: any suspected overdose with abnormal breathing, abnormal heart rate, or abnormal mental status is a 911 call. Do not wait for certainty.
Red-flag warnings that warrant immediate emergency activation: Breathing slower than roughly 10 breaths per minute or absent, or lips turning blue. Unresponsiveness or a level of consciousness that is falling. A racing, irregular, or very slow pulse with chest pain, fainting, or seizure. Known ingestion of a sodium-channel blocker, calcium-channel blocker, or sustained-release formulation. Polysubstance use involving opioids plus sedatives or alcohol. Any stimulant-associated chest pain, even if the person feels well.
Practical steps while waiting for help: give naloxone if opioid overdose is suspected and it is available, support breathing if trained, keep the person on their side to reduce aspiration risk, and stay with them. Do not induce vomiting. Do not leave a person who seems to recover, because delayed toxicity is real.
Limits of what this evidence supports
Mechanisms are stable and well established. Exact dose thresholds are not, and no article can tell an individual whether a specific amount will cause arrest. The published ranges are population patterns, and genetics, tolerance, organ function, and co-ingestants move every threshold. What is well supported is the sequence: depressants cause arrest through breathing, sodium-channel blockers through conduction, stimulants through ischemia and arrhythmia, and pressure agents through pump failure. That sequence is the reliable core. Specific numbers, including the ECG threshold and observation windows cited here, reflect standard toxicology teaching and should guide, not replace, clinical judgment. For any real emergency, the evidence is unanimous on one point: activate emergency services early.